Investigating the role of BACH1 in regulating inflammation in immune cells.
BACH1 as a novel pioneer repressor in macrophages: impact on homeostasis and inflammation
This study is looking at how a protein called BACH1 affects immune cells that help control inflammation, which could lead to new ways to treat inflammatory diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10954329 on NIH RePORTER |
What this research studies
This research focuses on understanding how a protein called BACH1 influences the behavior of macrophages, which are crucial immune cells involved in inflammation. By examining the mechanisms of transcriptional regulation, the study aims to uncover how BACH1 acts as a repressor that shapes the macrophage epigenome, impacting their differentiation and response to inflammation. The research employs advanced techniques like ATAC sequencing to analyze chromatin accessibility and gene expression patterns in macrophages. Patients may benefit from insights gained into inflammatory diseases and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with inflammatory conditions or diseases where macrophage function is disrupted.
Not a fit: Patients with non-inflammatory conditions or those not involving macrophage activity may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating inflammatory diseases by targeting the mechanisms regulated by BACH1.
How similar studies have performed: Other research has shown promising results in understanding transcriptional regulation in immune cells, suggesting that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Nagy, Laszlo — Johns Hopkins University
- Study coordinator: Nagy, Laszlo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.